In our study, we discovered that FLOT1 was widely over-expressed in bladder cancer TMAs (Fig. 5a and b), and was significantly down-regulated and accompanied with the decreased p-AKT and p-FOXO3a in miR-608 treated xenograft tumor (Fig. 5c). Here, FOXO3 is linked to urinary bladder carcinoma.